🏆 RGCC International proudly supports the Swiss Chemical Society’s Cancer Drug Discovery Research Award. This award celebrates the scientific achievements of Master’s, PhD students, and Postdocs at Swiss research institutes advancing #cancer drug discovery. #RGCCInternational

🏆 We're thrilled to highlight the array of certifications that hashtag#RGCC labs proudly hold, showcasing our ongoing dedication to maintaining the highest standards of quality and safety! 💼🔬 Check out our certifications on our website >> rgcc-international.com

RGCC SA joins the finest laboratories in the world accredited by the College of American CAPathologists. Learn more about our accreditations via rgcc-international.com

Delve into the world of cancer drug discovery with our peer-reviewed article! 👉 From statistical analysis to co-expression networks, we're paving the way for more effective treatments. Discover all our publications via rgcc-international.com/published-arti…

The Cancer Drug Discovery Research Award, supported by #RGCC and The Swiss Chemical Society is here to honor outstanding achievements in cancer drug discovery research. 👉Learn more: scg.ch/com.../pages/p… Swiss Chemical Society

At #RGCC, our vision is clear: A world where #cancer treatment is truly personalized, harnessing the power of innovative technologies and insights to provide tailored solutions for every individual. Learn more >> rgcc-international.com

🧪 Step into the epicenter of innovation at our #RGCC labs in Halle, #Germany! Here, we specialize in molecular biology, cell biology, and protein chemistry—fields that are revolutionizing the future of #cancer care.

How do liquid biopsies work? By detecting these markers, liquid biopsies can provide valuable insights into potential #cancer development, even before traditional methods show abnormalities. Watch this video to learn more: youtube.com/watch?v=GAipxj…

At #RGCC, excellence is at the core of everything we do. We’re proud to hold a range of prestigious certifications that reflect our commitment to the highest industry standards. 📷 Explore our full list of accreditations >> rgcc-international.com

Introducing InVyomma Plus, #RGCC's groundbreaking test delving into the intricate world of the gut microbiome. 🔗Learn more: rgcc-international.com/tests/invyomma…

At #RGCC, we believe that truly personalized cancer care begins with precision diagnostics. This testimonial highlights how informed decisions and expert-led protocols can make all the difference in treatment journeys. Read more testimonials here: rgcc-international.com/testimonials/

At RGCC, we support healthcare professionals in delivering precision #oncology through every stage of the patient journey, from early detection to long-term monitoring. 🧬Empower your clinical decisions with #RGCC’s suite of advanced tests: rgcc-international.com/tests/

In this groundbreaking episode of A Healthy Point of View, host Sam Tejada is joined by the CMO of Liquivida who is an interventional cardiologist, Dr. Christopher Davis and special guest Dr. Ioannis Papasotiriou, founder of RGCC Laboratories. Together, they dive deep into one of

Στην RGCC ο Υπουργός Ανάπτυξης, κος Παναγιώτης Θεοδωρικάκος news247.gr/publi/stin-rgc…

RGCC has announced the initiation of legal proceedings aimed at addressing the limited access of thousands of EU patients to EMA-approved ATMPs. Read the full statement here: rgcc-international.com/news/eu-equal-…

As part of its CSR activities, RGCC donates €15,000 to support CAR-T Cell therapy research at Charité – Universitätsmedizin Berlin. Read the full press release: rgcc-international.com/news/donation-…

If you or someone who love has CANCER, I urge you to look into an amazing test called RGCC. This test, takes a sample of your blood, analyzes it, breaks down its genetic sequence, and then gives the following pieces of information: 1. Circulating tumor cell count (CTC) 2.

A conducted real-world study shows that CTC analysis can guide personalized treatment and improve outcomes for women with advanced or recurrent ovarian #cancer. 🔬Read it here: sciencedirect.com/science/articl…

Developed through a collaboration between scientists & oncologists, our 2025 study examines the optimal strategy for adjusting second-line treatment for advanced pancreatic #cancer using circulating #tumor cells. You can read all our studies here rgcc-international.com/published-arti…

Throwback post for our in-depth review published in February 2024 by #RGCC scientists on survival analysis methods in clinical studies. This article explores both introductory and advanced techniques in survival modeling. Read it here: ar.iiarjournals.org/content/44/2/4…